383 related articles for article (PubMed ID: 11574414)
1. Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male wistar rats.
Hevener AL; Reichart D; Janez A; Olefsky J
Diabetes; 2001 Oct; 50(10):2316-22. PubMed ID: 11574414
[TBL] [Abstract][Full Text] [Related]
2. Female rats do not exhibit free fatty acid-induced insulin resistance.
Hevener A; Reichart D; Janez A; Olefsky J
Diabetes; 2002 Jun; 51(6):1907-12. PubMed ID: 12031980
[TBL] [Abstract][Full Text] [Related]
3. Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo.
Park E; Wong V; Guan X; Oprescu AI; Giacca A
J Endocrinol; 2007 Nov; 195(2):323-31. PubMed ID: 17951543
[TBL] [Abstract][Full Text] [Related]
4. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
[TBL] [Abstract][Full Text] [Related]
5. Dose-response effect of elevated plasma free fatty acid on insulin signaling.
Belfort R; Mandarino L; Kashyap S; Wirfel K; Pratipanawatr T; Berria R; Defronzo RA; Cusi K
Diabetes; 2005 Jun; 54(6):1640-8. PubMed ID: 15919784
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol prevents insulin resistance caused by short-term elevation of free fatty acids in vivo.
Pereira S; Park E; Moore J; Faubert B; Breen DM; Oprescu AI; Nahle A; Kwan D; Giacca A; Tsiani E
Appl Physiol Nutr Metab; 2015 Nov; 40(11):1129-36. PubMed ID: 26455923
[TBL] [Abstract][Full Text] [Related]
7. Prior thiazolidinedione treatment preserves insulin sensitivity in normal rats during acute fatty acid elevation: role of the liver.
Ye JM; Frangioudakis G; Iglesias MA; Furler SM; Ellis B; Dzamko N; Cooney GJ; Kraegen EW
Endocrinology; 2002 Dec; 143(12):4527-35. PubMed ID: 12446579
[TBL] [Abstract][Full Text] [Related]
8. Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects.
Wilmsen HM; Ciaraldi TP; Carter L; Reehman N; Mudaliar SR; Henry RR
Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E354-62. PubMed ID: 12700163
[TBL] [Abstract][Full Text] [Related]
9. Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin.
Willi SM; Kennedy A; Wallace P; Ganaway E; Rogers NL; Garvey WT
Diabetes; 2002 Oct; 51(10):2895-902. PubMed ID: 12351424
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients.
Miyazaki Y; He H; Mandarino LJ; DeFronzo RA
Diabetes; 2003 Aug; 52(8):1943-50. PubMed ID: 12882909
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
Miles PD; Higo K; Romeo OM; Lee MK; Rafaat K; Olefsky JM
Diabetes; 1998 Mar; 47(3):395-400. PubMed ID: 9519745
[TBL] [Abstract][Full Text] [Related]
12. Exercise and thiazolidinedione therapy normalize insulin action in the obese Zucker fatty rat.
Hevener AL; Reichart D; Olefsky J
Diabetes; 2000 Dec; 49(12):2154-9. PubMed ID: 11118020
[TBL] [Abstract][Full Text] [Related]
13. Effects of troglitazone on hepatic and peripheral insulin resistance induced by growth hormone excess in rats.
Sugimoto M; Takeda N; Nakashima K; Okumura S; Takami K; Yoshino K; Hattori J; Ishimori M; Takami R; Sasaki A; Yasuda K
Metabolism; 1998 Jul; 47(7):783-7. PubMed ID: 9667221
[TBL] [Abstract][Full Text] [Related]
14. Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle.
Kim YB; Zhu JS; Zierath JR; Shen HQ; Baron AD; Kahn BB
Diabetes; 1999 Feb; 48(2):310-20. PubMed ID: 10334307
[TBL] [Abstract][Full Text] [Related]
15. Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) action.
Zierath JR; Ryder JW; Doebber T; Woods J; Wu M; Ventre J; Li Z; McCrary C; Berger J; Zhang B; Moller DE
Endocrinology; 1998 Dec; 139(12):5034-41. PubMed ID: 9832442
[TBL] [Abstract][Full Text] [Related]
16. Infusion of beta-endorphin improves insulin resistance in fructose-fed rats.
Su CF; Chang YY; Pai HH; Liu IM; Lo CY; Cheng JT
Horm Metab Res; 2004 Aug; 36(8):571-7. PubMed ID: 15326568
[TBL] [Abstract][Full Text] [Related]
17. Free fatty acids and insulin resistance during pregnancy.
Sivan E; Homko CJ; Whittaker PG; Reece EA; Chen X; Boden G
J Clin Endocrinol Metab; 1998 Jul; 83(7):2338-42. PubMed ID: 9661605
[TBL] [Abstract][Full Text] [Related]
18. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.
Oakes ND; Thalén PG; Jacinto SM; Ljung B
Diabetes; 2001 May; 50(5):1158-65. PubMed ID: 11334421
[TBL] [Abstract][Full Text] [Related]
19. Effects of troglitazone and voluntary running on insulin resistance induced high fat diet in the rat.
Kitakoshi K; Oshida Y; Nakai N; Han YQ; Sato Y
Horm Metab Res; 2001 Jun; 33(6):365-9. PubMed ID: 11456287
[TBL] [Abstract][Full Text] [Related]
20. Effects of troglitazone on dexamethasone-induced insulin resistance in rats.
Okumura S; Takeda N; Takami K; Yoshino K; Hattori J; Nakashima K; Sugimoto M; Ishimori M; Takami R; Yasuda K
Metabolism; 1998 Mar; 47(3):351-4. PubMed ID: 9500576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
